BioCentury | Dec 12, 2019
Tools & Techniques

New hepatic stellate cell subset drives liver fibrosis

...antagonists: Bristol-Myers Squibb Co. (NYSE:BMY) has BMS-986278 in Phase I testing for pulmonary fibrosis, and Epigen Biosciences Inc....
Items per page:
1 - 1 of 1
BioCentury | Dec 12, 2019
Tools & Techniques

New hepatic stellate cell subset drives liver fibrosis

...antagonists: Bristol-Myers Squibb Co. (NYSE:BMY) has BMS-986278 in Phase I testing for pulmonary fibrosis, and Epigen Biosciences Inc....
Items per page:
1 - 1 of 1